Searching journal content for adrenocortical carcinoma (as phrase) in full text.

Displaying results 1-10 of 88
For checked items
  1. Thematic Review:
    • Lucas Leite Cunha,
    • Marjory Alana Marcello,
    • Vinicius Rocha-Santos,
    • and Laura Sterian Ward
    Immunotherapy against endocrine malignancies: immune checkpoint inhibitors lead the way Endocr Relat Cancer 24 (12) T261-T281, doi:10.1530/ERC-17-0222 first published on 11 September 2017
    ...adrenocortical carcinoma and neuroendocrine tumors. We present the challenges and the opportunities of using immune checkpoint inhibitors against these endocrine malignancies, highlighting the breakthroughs and pitfalls that have recently emerged. Introduction Immune checkpoint inhibitors are agents ~~~
  2. Thematic Review:
    • Stephan Gasser,
    • Lina H K Lim,
    • and Florence S G Cheung
    The role of the tumour microenvironment in immunotherapy Endocr Relat Cancer 24 (12) T283-T295, doi:10.1530/ERC-17-0146 first published on 28 July 2017
    ...adrenocortical carcinoma . International Journal of Endocrine Oncology 1 173 – 182 . ( doi:10.2217/ije.14.13 ) ↵ Azad A , Yin Lim S , D’Costa Z , Jones K , Diana A , Sansom OJ , Kruger P , Liu S , McKenna WG , Dushek O et al. 2017 PD-L1 blockade enhances response of pancreatic ductal adenocarcinoma ~~~
  3. Thematic Review:
    • Jerena Manoharan,
    • Max B Albers,
    • and Detlef K Bartsch
    The future: diagnostic and imaging advances in MEN1 therapeutic approaches and management strategies Endocr Relat Cancer 24 (10) T209-T225, doi:10.1530/ERC-17-0231 first published on 8 August 2017
    ...adrenocortical carcinoma (ACC), but this is a life-threatening malignant tumor (Skogseid et al. 1995, Gibril et al. 2004, Waldmann et al. 2007). Biochemical investigation, including plasma renin, aldosterone and cortisol concentrations and lowdose dexamethasone suppression test, is recommended in ME ~~~
  4. Research Letter:
    • Lucie Evenepoel,
    • Raphaël Helaers,
    • Laurent Vroonen,
    • Selda Aydin,
    • Marc Hamoir,
    • Dominique Maiter,
    • Miikka Vikkula,
    • and Alexandre Persu
    KIF1B and NF1 are the most frequently mutated genes in paraganglioma and pheochromocytoma tumors Endocr Relat Cancer 24 (8) L57-L61, doi:10.1530/ERC-17-0061 first published on 17 May 2017
    ...adrenocortical carcinoma . Nature Genetics 46 607 – 612 . ( doi:10.1038/ng.2953 ) ↵ Burnichon N , Vescovo L , Amar L , Libe R , de Reynies A , Venisse A , Jouanno E , Laurendeau I , Parfait B , Bertherat J et al. 2011 Integrative genomic analysis reveals somatic mutations in pheochromocytoma and par ~~~
  5. Research:
    • Elisa Roca,
    • Alfredo Berruti,
    • Silviu Sbiera,
    • Ida Rapa,
    • Ester Oneda,
    • Paola Sperone,
    • Cristina L Ronchi,
    • Laura Ferrari,
    • Salvatore Grisanti,
    • Antonina Germano,
    • Barbara Zaggia,
    • Giorgio Vittorio Scagliotti,
    • Martin Fassnacht,
    • Marco Volante,
    • Massimo Terzolo,
    • and Mauro Papotti
    Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer Endocr Relat Cancer 24 (7) 319-327, doi:10.1530/ERC-17-0095 first published on 21 April 2017
    ...adrenocortical carcinoma 10.1530/ERC-17-0095 Elisa Roca1, Alfredo Berruti1, Silviu Sbiera2, Ida Rapa3, Ester Oneda1, Paola Sperone4, Cristina L Ronchi2, Laura Ferrari1, Salvatore Grisanti1, Antonina Germano5, Barbara Zaggia5, Giorgio Vittorio Scagliotti4, Martin Fassnacht2, Marco Volante3, Massimo T ~~~
  6. Review:
    • Anna Angelousi,
    • Georgios K Dimitriadis,
    • Georgios Zografos,
    • Svenja Nölting,
    • Gregory Kaltsas,
    • and Ashley Grossman
    Molecular targeted therapies in adrenal, pituitary and parathyroid malignancies Endocr Relat Cancer 24 (6) R239-R259, doi:10.1530/ERC-16-0542 first published on 11 April 2017
    ...adrenocortical carcinoma cells. Endocrine 52 664–677. (doi:10.1007/s12020-015-0818-0) Del Basso De Caro M, Solari D, Pagliuca F, Villa A, Guadagno E, Cavallo LM, Colao A, Pettinato G & Cappabianca P 2016 Atypical pituitary adenomas: clinical characteristics and role of ki-67 and p53 in prognostic an ~~~
  7. Review:
    • Georgios K Dimitriadis,
    • Anna Angelousi,
    • Martin O Weickert,
    • Harpal S Randeva,
    • Gregory Kaltsas,
    • and Ashley Grossman
    Paraneoplastic endocrine syndromes Endocr Relat Cancer 24 (6) R173-R190, doi:10.1530/ERC-17-0036 first published on 24 March 2017
    ...adrenocortical carcinoma secreting IGF2 not responding to everolimus was recently reported by Korevaar and coworkers (Korevaar  et  al. 2014). It appears that either IGF2 does not cause hypoglycaemia by activation of the insulin receptor, which is improbable, or that the mode of action of everolimus ~~~
  8. Review:
    • Alfred King-yin Lam
    Lipomatous tumours in adrenal gland: WHO updates and clinical implications Endocr Relat Cancer 24 (3) R65-R79, doi:10.1530/ERC-16-0564 first published on 31 January 2017
    ...adrenocortical carcinoma reported to be having a component of adipose tissue ( Izumi et al . 2003 , Heye et al . 2005 , Egbert et al . 2010 ). The tumours were noted in left adrenal, functional and in male patients. One of them is a myxoid variant of adrenocortical carcinoma ( Izumi et al . 2003 ). ~~~
  9. Research:
    • Sara Jung,
    • Zoltan Nagy,
    • Martin Fassnacht,
    • Gerard Zambetti,
    • Max Weiss,
    • Martin Reincke,
    • Peter Igaz,
    • Felix Beuschlein,
    • and Constanze Hantel
    Preclinical progress and first translational steps for a liposomal chemotherapy protocol against adrenocortical carcinoma Endocr Relat Cancer 23 (10) 825-837, doi:10.1530/ERC-16-0249 first published on 22 August 2016
    ...adrenocortical carcinoma (ACC) is limited by heterogeneous tumor response and adverse effects. Recently, we demonstrated anti-tumor activity of LEDP-M (etoposide, liposomal doxorubicin, liposomal cisplatin, mitotane), a liposomal variant of EDP-M (etoposide, doxorubicin, cisplatin, mitotane). To imp ~~~
  10. Research:
    • S G Creemers,
    • P M van Koetsveld,
    • F J van Kemenade,
    • T G Papathomas,
    • G J H Franssen,
    • F Dogan,
    • E M W Eekhoff,
    • P van der Valk,
    • W W de Herder,
    • J A M J L Janssen,
    • R A Feelders,
    • and L J Hofland
    Methylation of IGF2 regulatory regions to diagnose adrenocortical carcinomas Endocr Relat Cancer 23 (9) 727-737, doi:10.1530/ERC-16-0266
    ...adrenocortical carcinoma f biomarker f DNA methylation f epigenetics f IGF2 728Research S G Creemers et al. Methylation of IGF2 regulatory regions in ACCs DOI: 10.1530/ERC-16-0266 http://.endocrinology-journals.org © 2016 Society for Endocrinology Printed in Great Britain Published by Bioscientifica ~~~
For checked items

Search Results

Next 10 » New Search

Modify Results

Citation format:
Results / page:
Results order:

This search

  • Alert me when new articles matching this search are published
  • Download all citations on this page to my citation manager

New Articles: issue in progress

  1. December 2017, 24 (12)
  1. Current Issue
  1. Alert me to new issues of Endocrine-Related Cancer

Most